![The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_724446_16625550831294060.jpg)
The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants
![Ministry of Health on Twitter: "The time interval between two doses of the Covishield vaccine revised from 4-6 weeks to 4-8 weeks to ensure better protection. #LargestVaccineDrive #Unite2FightCorona https://t.co/yb0cSj7xy7" / Twitter Ministry of Health on Twitter: "The time interval between two doses of the Covishield vaccine revised from 4-6 weeks to 4-8 weeks to ensure better protection. #LargestVaccineDrive #Unite2FightCorona https://t.co/yb0cSj7xy7" / Twitter](https://pbs.twimg.com/media/ExPKWfxUcAgV5EH.jpg)
Ministry of Health on Twitter: "The time interval between two doses of the Covishield vaccine revised from 4-6 weeks to 4-8 weeks to ensure better protection. #LargestVaccineDrive #Unite2FightCorona https://t.co/yb0cSj7xy7" / Twitter
![COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/publications/2021/11/covid-19-vaccines-the-difference-between-the-third-dose-and-a-booster-dose-easy-read.png)
COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care
Booster Shots and Additional Doses for COVID-19 Vaccines — What You Need to Know | Johns Hopkins Medicine
Ministry of Health - Manatū Hauora - We are moving to a six-week gap between first and second doses because it allows us to give one dose to a larger number of
![CDC shortens wait time between primary vaccine series and booster doses for immunocompromised people : Oregon Health News Blog CDC shortens wait time between primary vaccine series and booster doses for immunocompromised people : Oregon Health News Blog](https://i0.wp.com/covidblog.oregon.gov/wp-content/uploads/2022/02/booster-syringe_cropped.jpg?resize=708%2C280&ssl=1)
CDC shortens wait time between primary vaccine series and booster doses for immunocompromised people : Oregon Health News Blog
![Vaccines | Free Full-Text | Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study Vaccines | Free Full-Text | Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study](https://pub.mdpi-res.com/vaccines/vaccines-10-02123/article_deploy/html/images/vaccines-10-02123-g003.png?1671001571)
Vaccines | Free Full-Text | Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study
World Health Organization (WHO) - What's the difference between COVID-19 vaccine efficacy and effectiveness❓ ✓ Vaccine efficacy refers to how the vaccine performs in ideal conditions – controlled clinical trials ✓ Vaccine
![Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases | Pew Research Center Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases | Pew Research Center](https://www.pewresearch.org/science/wp-content/uploads/sites/16/2020/12/PS_2020.12.03_covid19-vaccine-intent_00-01.png)
Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases | Pew Research Center
![COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm705152a1_VaccineSafetyChildren_Image_31Dec21_1200x675.jpg)
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR
![Sask. to receive 15K AstraZeneca vaccines in March; time between 1st and 2nd doses of all vaccines expanded | CTV News Sask. to receive 15K AstraZeneca vaccines in March; time between 1st and 2nd doses of all vaccines expanded | CTV News](https://www.ctvnews.ca/polopoly_fs/1.5303285.1615909406!/httpImage/image.jpg_gen/derivatives/landscape_1020/image.jpg)
Sask. to receive 15K AstraZeneca vaccines in March; time between 1st and 2nd doses of all vaccines expanded | CTV News
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x675-medium.jpg?_=39295)